(Q44024922)
Statements
1 reference
A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm (English)
1 reference
J D Cox
1 reference
N Azarnia
1 reference
R W Byhardt
1 reference
K H Shin
1 reference
B Emami
1 reference
T F Pajak
1 reference
1 September 1990
1 reference
1 reference
Identifiers
1 reference